We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

New Imaging Technology Detects Gastric Lymphomas

By MedImaging International staff writers
Posted on 13 Oct 2021
Print article
Image: MALT lymphomas express the chemokine receptor CXCR4 (Photo courtesy of MedUni)
Image: MALT lymphomas express the chemokine receptor CXCR4 (Photo courtesy of MedUni)
A new imaging technique for the detection of gastric mucosa-associated lymphoid tissue (MALT) lymphomas could reduce invasive gastroscopy biopsies, according to a new study.

The study, by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY, USA), the Medical University of Vienna (MedUni; Austria), and other institutions, explored if [68Ga]Pentixafor, a positron emission tomography (PET) tracer that targets the chemokine receptor CXCR4 (which is overexpressed in MALT lymphoma), could serve as a potential alternative to follow-up biopsies for assessment of residual disease following first-line H. pylori eradication.

The study, which included [68Ga]Pentixafor-PET and magnetic resonance imaging (MRI) scans in 26 gastric MALT lymphoma patients and 20 control group patients without lymphoma, showed that accuracy, sensitivity, specificity, and positive and negative predictive value of [68Ga]Pentixafor-PET for detection of residual gastric MALT lymphoma at follow-up were 97%, 95%, 100%, 100%, and 92.9%, respectively. Maximum and mean PET standardized uptake values also showed correlation with immunohistochemistry-based CXCR4 cell counts. The study was published on September 15, 2021, in Blood.

“Post-treatment evaluation of gastric MALT currently relies on esophagogastroduodenoscopy with histological assessment of biopsies,” concluded lead author Marius Mayerhöfer, PhD, of the MedUni department of biomedical imaging and image-guided therapy, and colleagues. “If a sufficiently high CXCR4 expression is detected at the initial diagnosis of MALT lymphoma, the new imaging could replace repeated gastroscopies in the course of the disease in the future, or at least increase the time intervals between gastroscopies.”

CXCR4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1), a molecule with potent chemotactic activity for lymphocytes. After attachment to SDF-1, the CXCR4 protein activates signaling pathways inside the cell that help regulate cell growth and proliferation. CXCR4 is also involved in cell migration cells, especially hematopoietic stem cells in the bone marrow.

Related Links:
Memorial Sloan-Kettering Cancer Center
Medical University of Vienna

Gold Supplier
Conductive Gel
Gold Supplier
128 Slice CT Scanner
Supria 128
Radiographic System
RADspeed Pro Style Edition V Series
Interventional Robot

Print article
Sun Nuclear -    Mirion



view channel
Image: Radiologists outperformed AI in identifying lung diseases on chest X-ray (Photo courtesy of RSNA)

Radiologists Beat AI in Detecting Common Lung Diseases on Chest X-Rays

Chest X-rays are frequently used for diagnosis, but it takes a lot of training and expertise to read these images correctly. Although the Food and Drug Administration (FDA) has approved some artificial... Read more


view channel
Image: The new device targets ultrasound waves to precise spots in the brain (Photo courtesy of WUSTL)

Anatomically Precise Ultrasound-Based Technique to Enable Noninvasive Biopsies for Brain Tumors

The blood-brain barrier serves as a protective wall, keeping the brain safe from harmful elements like viruses and toxins in the blood. This makes it challenging for doctors to obtain molecular and genetic... Read more

Nuclear Medicine

view channel
Image: Imaging entire body instead of only the primary cancer site can provide a total estimate of HER2 expression (Photo courtesy of 123RF)

Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients

Around 20% of women diagnosed with breast cancer show overexpression of human epidermal growth factor receptor 2 (HER2), making it a key therapy target for new as well as recurring cases.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The partnership combines best-in-class AI-powered technologies for musculoskeletal imaging workflows (Photo courtesy of ImageBiopsy Lab)

AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis

Musculoskeletal (MSK) conditions impact more people worldwide than issues related to the circulatory or respiratory systems. Even so, diagnostic procedures for these conditions often still lean on outdated... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.